Rhythm Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
RYTM Nasdaq 8731 http://www.rhythmtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Announces New Employment Inducement Grants - Apr 16th, 2024 8:01 pm
Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Apr 14th, 2024 12:46 pm
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains? - Apr 10th, 2024 10:40 am
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing - Apr 1st, 2024 12:00 pm
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist - Mar 25th, 2024 12:00 pm
Chief Technical Officer Joseph Shulman Sells 18,235 Shares of Rhythm Pharmaceuticals Inc (RYTM) - Mar 22nd, 2024 11:01 pm
Insider Sell: Rhythm Pharmaceuticals Inc (RYTM) CEO David Meeker Disposes of 45,494 Shares - Mar 20th, 2024 5:49 am
Insider Sell: Chief Technical Officer Joseph Shulman Sells 15,515 Shares of Rhythm ... - Mar 20th, 2024 5:49 am
Insider Sell: CFO Hunter Smith Sells 15,515 Shares of Rhythm Pharmaceuticals Inc (RYTM) - Mar 20th, 2024 5:49 am
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences - Mar 6th, 2024 9:01 pm
Rhythm Pharmaceuticals Full Year 2023 Earnings: Revenues Disappoint - Mar 3rd, 2024 12:40 pm
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Feb 24th, 2024 1:49 pm
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript - Feb 23rd, 2024 5:04 pm
Q4 2023 Rhythm Pharmaceuticals Inc Earnings Call - Feb 23rd, 2024 3:19 am
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Misses Revenue Estimates - Feb 22nd, 2024 1:10 pm
Rhythm Pharmaceuticals Inc (RYTM) Reports Q4 and Full Year 2023 Financial Results - Feb 22nd, 2024 12:35 pm
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan - Feb 22nd, 2024 12:01 pm
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update - Feb 22nd, 2024 12:00 pm
Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline - Feb 20th, 2024 3:00 pm
Chief Technical Officer Joseph Shulman Sells Shares of Rhythm Pharmaceuticals Inc - Feb 16th, 2024 8:00 am